Fig 1.
Mean values of personal, medication and infrastructure costs per case in Euro for patients with paranoid SZ (blue) and SAD (red).
The ends of the whiskers indicate the standard deviation. Note that these partial costs do not exactly add up to the amount of total costs, since we did not compare costs for materials other than medication.
Table 1.
Demographic characteristics and costs (n = 189).
Fig 2.
Average daily costs in Euro of inpatient treatment of patients with paranoid SZ (blue-green graphs) and SAD (red-yellow).
The timeline does not represent a calendar period of one year but a transformation where all individual treatment courses start at day one of the presented timeline. Note that the number of averaged cases decreases over time. with less than 5 patients received longer treatments than 154 days (i.e. for 167, 180, 183 and 253 days respectively). This results in higher fluctuations of daily means.